211 related articles for article (PubMed ID: 11319616)
41. Observations with tumour necrosis factor gene-transfected tumours.
Blankenstein T
Folia Biol (Praha); 1994; 40(1-2):19-28. PubMed ID: 7958061
[TBL] [Abstract][Full Text] [Related]
42. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
43. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
44. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
45. Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect.
Liu X; Zhang L; Zhang M; Ma Y; Xu X; Cai Y
Chin Med J (Engl); 2000 Feb; 113(2):167-71. PubMed ID: 11775545
[TBL] [Abstract][Full Text] [Related]
46. Therapy combining tumor necrosis factor with tumor-specific antibody against Meth A sarcoma.
Satomi N; Sakurai A; Haranaka R; Haranaka K
J Biol Response Mod; 1989 Oct; 8(5):528-38. PubMed ID: 2677250
[TBL] [Abstract][Full Text] [Related]
47. Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.
Zang Z; Mahendran R; Wu Q; Yong T; Esuvaranathan K
Int J Mol Med; 2004 Oct; 14(4):713-7. PubMed ID: 15375606
[TBL] [Abstract][Full Text] [Related]
48. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
Xia D; Moyana T; Xiang J
Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
[TBL] [Abstract][Full Text] [Related]
49. Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways.
Cheng WF; Hung CF; Lee CN; Su YN; Chang MC; He L; Wu TC; Chen CA; Hsieh CY
Eur J Immunol; 2004 Jul; 34(7):1892-900. PubMed ID: 15214037
[TBL] [Abstract][Full Text] [Related]
50. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
51. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
52. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
53. Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors.
Mizuguchi H; Nakagawa T; Toyosawa S; Nakanishi M; Imazu S; Nakanishi T; Tsutsumi Y; Nakagawa S; Hayakawa T; Ijuhin N; Mayumi T
Cancer Res; 1998 Dec; 58(24):5725-30. PubMed ID: 9865730
[TBL] [Abstract][Full Text] [Related]
54. Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancer.
Ciavarra RP; Somers KD; Brown RR; Glass WF; Consolvo PJ; Wright GL; Schellhammer PF
Cancer Res; 2000 Apr; 60(8):2081-4. PubMed ID: 10786663
[TBL] [Abstract][Full Text] [Related]
55. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline.
Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
Gene Ther; 1994 Jul; 1(4):269-75. PubMed ID: 7584091
[TBL] [Abstract][Full Text] [Related]
56. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
57. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
[TBL] [Abstract][Full Text] [Related]
58. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA
J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720
[TBL] [Abstract][Full Text] [Related]
59. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
Inagawa H; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
[TBL] [Abstract][Full Text] [Related]
60. A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression.
Ogawa M; Umehara K; Yu WG; Uekusa Y; Nakajima C; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1999 Apr; 59(7):1531-8. PubMed ID: 10197625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
